Scottish Gynaecological Cancer Study Group Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01837251
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

SGCTG: The Scottish Gynaecological Cancer Trials Group, UK